Pharma Journalist -

BeiGene, a global oncology company, and NewBridge Pharmaceuticals have jointly decided to conclude their partnership. This strategic decision aligns with BeiGene’s goals to expand its…
Read More...

AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. announced a license agreement to develop FG-M701, a next generation TL1A antibody for the treatment of IBD currently in…
Read More...

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors CPHI & PMEC China (June 19-21st) returns to the Shanghai…
Read More...

Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s disease (AD)…
Read More...

AstraZeneca’s Farxiga (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycaemic control in paediatric patients with type-2 diabetes (T2D)…
Read More...

Flagship Pioneering and ProFound™ Therapeutics, a Flagship-founded company pioneering the expanded human proteome to develop novel medicines for a multitude of diseases, announced a…
Read More...

IQVIA announced the launch of One Home for Sites, a new technology platform that acts as a single sign-on and a single dashboard for the key systems and tasks a clinical research site…
Read More...

GSK plc announced that it has acquired Elsie Biotechnologies, a San Diego-based private biotechnology company dedicated to unlocking the full potential of oligonucleotide therapeutics,…
Read More...

Cycle Pharmaceuticals Ltd, a rapidly growing pharmaceutical company focused on treatments for the underserved rare disease patient community, today confirmed that it made a proposal to…
Read More...

In the wake of significant achievements in synthetic peptide therapeutics, such as Novo Nordisk’s $6 billion peptide expansion, Merck’s advancements in macrocyclic peptides, and…
Read More...